Long-term efficacy and safety of botulinum toxin treatment for cervical dystonia: a critical reappraisal.
作者： Carlo Colosimo , Joseph Jankovic , Matteo Bologna , Luca Marsili
DOI: 10.1080/14740338.2021.1915282
关键词: Discontinuation 、 Medicine 、 Cervical dystonia 、 Botulinum neurotoxin 、 Drop out 、 Adverse effect 、 Internal medicine 、 Botulinum toxin 、 Long term treatment
摘要: Introduction: Botulinum toxin (BoNT) injections represent the gold standard treatment for cervical dystonia (CD). Different types of BoNT have been used for the treatment of CD, but only …
sci-hub.st 参考文章(76)
Gonçalo S Duarte, Mafalda Castelão, Filipe B Rodrigues, Raquel E Marques, Joaquim Ferreira, Cristina Sampaio, Austen P Moore, João Costa, Botulinum toxin type A versus botulinum toxin type B for cervical dystonia Cochrane Database of Systematic Reviews. ,vol. 10, ,(2016) , 10.1002/14651858.CD004314.PUB3
João Costa, Cláudia C Espírito‐Santo, Ana A Borges, Joaquim Ferreira, Miguel M Coelho, Peter Moore, Cristina Sampaio, Botulinum toxin type A therapy for cervical dystonia. Cochrane Database of Systematic Reviews. ,vol. 12, pp. 0- 0 ,(2005) , 10.1002/14651858.CD003633.PUB3
Wolfgang H. Jost, Laurent Tatu, Selection of Muscles for Botulinum Toxin Injections in Cervical Dystonia. Movement Disorders Clinical Practice. ,vol. 2, pp. 224- 226 ,(2015) , 10.1002/MDC3.12172
Raquel E Marques, Gonçalo S Duarte, Filipe B Rodrigues, Mafalda Castelão, Joaquim Ferreira, Cristina Sampaio, A Peter Moore, João Costa, Botulinum toxin type B for cervical dystonia. Cochrane Database of Systematic Reviews. ,(2016) , 10.1002/14651858.CD004315.PUB3
J. M. Ritter, Drug regulation & therapeutic efficacy British Journal of Clinical Pharmacology. ,vol. 65, pp. 801- 802 ,(2008) , 10.1111/J.1365-2125.2008.03208.X
G-Y.R. Hsiung, S.K. Das, R. Ranawaya, A.-L. Lafontaine, O. Suchowersky, Long-term efficacy of botulinum toxin A in treatment of various movement disorders over a 10-year period. Movement Disorders. ,vol. 17, pp. 1288- 1293 ,(2002) , 10.1002/MDS.10252
J.W.M. Brans, R. Lindeboom, J.W. Snoek, M.J. Zwarts, T.W. van Weerden, E.R.P. Brunt, J.J. van Hilten, W. van der Kamp, M.H. Prins, J.D. Speelman, Botulinum toxin versus trihexyphenidyl in cervical dystonia A prospective, randomized, double-blind controlled trial Neurology. ,vol. 46, pp. 1066- 1072 ,(1996) , 10.1212/WNL.46.4.1066
Carla Cordivari, Vijay Peter Misra, Angela Vincent, Santiago Catania, Kailash P. Bhatia, Andrew John Lees, Secondary nonresponsiveness to botulinum toxin A in cervical dystonia: the role of electromyogram-guided injections, botulinum toxin A antibody assay, and the extensor digitorum brevis test. Movement Disorders. ,vol. 21, pp. 1737- 1741 ,(2006) , 10.1002/MDS.21051
Cynthia L Comella, Joseph Jankovic, Daniel D Truong, Angelika Hanschmann, Susanne Grafe, US XEOMIN Cervical Dystonia Study Group, None, Efficacy and safety of incobotulinumtoxinA (NT 201, XEOMIN®, botulinum neurotoxin type A, without accessory proteins) in patients with cervical dystonia Journal of the Neurological Sciences. ,vol. 308, pp. 103- 109 ,(2011) , 10.1016/J.JNS.2011.05.041
B. Mohammadi, N. Buhr, H. Bigalke, K. Krampfl, R. Dengler, K. Kollewe, A long-term follow-up of botulinum toxin A in cervical dystonia. Neurological Research. ,vol. 31, pp. 463- 466 ,(2009) , 10.1179/174313209X405137